Luteolin induces N-acetylation and DNA adduct of 2-aminofluorene acompanying N-acetyltransferase activity and gene expression in human bladder cancer T24 cell line

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 355-362

  Su, Chin Cheng ^a   Chen, Guang Wei ^a   Yeh, Chin Chung ^a   Yang, Mei Due ^a   Hung, Chi Fu ^c   Chung, Jing Gung ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c JEN AI HOSPITAL   (Taiwan)

Author keywords

Arylamine (N acetyl 2 aminofluorene and 2 aminofluorene); Human and mouse leukemia cells; Luteolin; N acetyltransferase

Indexed keywords

2 FLUORENYLAMINE; ACYLTRANSFERASE; LUTEOLIN;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEADY STATE;

ACETYLATION; AGED; AGED, 80 AND OVER; ARYLAMINE N-ACETYLTRANSFERASE; CYTOSOL; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; FLUORENES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; LUTEOLIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0344453792     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dybing E and Huitfeldt MS: Species differences in carcinogen metabolism and interspecies extrapolation. IARC Scientific Publication 116: 501-522, 1992.
2. Weber WW and Hein DW: N-acetylation pharmacogenetics. Pharmacol Rev 37: 25-99, 1985.
3. Evans DAP: N-acetyltransferase. Pharmacol Ther 42: 157-234, 1989.
4. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flamang TJ and Kadlubar FF: Role of aromatic amine acetyltranferase in human colorectal cancer. Arch Surg 121: 1259-1261, 1986.
5. Iletti KF, David BM, Detchon P, Castledon WM and Kwa R: Acetylator phenotype in colorectal carcinoma. Cancer Res 47: 1466-1469, 1987.
6. Cartwright RA, Glashami RW, Rogers HJ, Ahmed RA, Barham-Hall D, Higgens E and Kahn MA: Role of N-acetyltransferase phenotype in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842-846, 1982.
7. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino K and Aoike A: Genistein arrests cell cycle progressionat G2-M. Cancer Res 53: 1328-1331, 1993.
8. Ryu SY, Choi SU, Lee CO, Lee SH, Ahn JW and Zee OP: Antitumor activity of some phonolic components in plants. Arch Pharmacol Res 17: 42-44, 1994.
9. Ko WG, Kang TH, Lee SJ, Kim YC and Lee BH: Effects of luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukemia cells. Phytother Res 16: 295-298, 2002.
10. Hertog MGL, Hollman PCH and Katan MB: Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Arg Fd Chem 40: 2379-2383, 1992.
11. Huang MT, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM and Conney AH: Inhibition of the mutagenicity of bay region diol epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 4: 1631-1638, 1983.
12. Pettit GR, Hoard MS, Doubek DL, Schmidt JM, Pettit RK, Tackett LP and Chapus JC: Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Vombretaceae). J Ethnopharmacol 53: 57-63, 1996.
13. Li YC, Hung CF, Yeh FT, Lin Jp and Chung JG: Chung: Luteolin-inhibited arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human and mice leukemia cells. Food and Chemical Toxicology 39: 641-647, 2001.
14. Chung JG, Chang HL, Lin WC, Wang HH, Yeh CC, Hung CF and Li YC: Inhibitory of N-acetyltransferase activity and DNA-2-aminofluorene adducts by glycyrrhizic acid in human colon tumour cells. Food and Chem Toxicol 38: 163-172, 2000.
15. Bradfore MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
16. Chung JG: Paeonol promotion of DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumour cells. Food and Chem Toxicol 37: 327-334, 1999.
17. Ponte P, Ng SY, Engel J, Gunning P and Kedes L: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA, Nucleic Acids Res 12: 1687-1696, 1984.
18. Blum M, Grant DM, McBride W, Heim M and Myere UA: Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9: 193-203, 1990.
19. Cleland WW: The statistical analysis of enzyme kinetics data. Adv Enzymol 29: 1-32.
20. Levy GN, Chumg JG and Weber WW: 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis 15: 353-357, 1994.
21. Grant DM, Blum M, Beer M and Meyer UA: Monomorphic and polymorphic human arylamine N-acetyltransferase: A comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39: 184-191, 1991.
22. Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi T, Ilett KF and Kadlubar FF: N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem Biophs Res Commun 185: 839-844, 1992.
23. Smith G, Stanley LA, Sim E, Strange RC and Wolf CR: Metabolic polymorphisms and cancer susceptibility. Cancer Serv 25: 27-65, 1995.
24. Thorgeirsson SS, Glowinski IB and McManus ME: Metabolism, mutagenicity, carcinogenicity of aromatic amines. In: J. Hodgson, J. Bend and R.M. Philpot (Eds.,), Reviews in Biochemical Toxicity, Vol. 6, Elsevier/North Holland Biomedical Press, New York, pp. 349-386, 1983.
25. Ferriola PC, Cody V and Middleton Jr E: Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 15: 1617-1624, 1989.
26. Hayes MA, Roberts E, Safe SH, Farber E and Cameron RG: Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver. JNCI 76: 683-690, 1986.
27. Shimoi K, Okada H, Furugon M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H and Kinae N: Intestinal absorption of luteolin and luteolin 7-O-β-glucoside in rats and humans. FEBS Lett 438: 220-234, 1995.
28. Fisher RF and Long SR: DNA footprint analysis of the transcriptional activator proteins NodD1 and NodD3 on inducible nod gene promotes. J Bacteriol 171: 5492-5502, 1989.
29. RoyChowdhury A, Sharma S, Mandal S, Goswami A, Mukhopadhyay A and Majumder HK: Luteolin, an emerging anti cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem J 23: 23-31, 2002.
30. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H and Aoike A: Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1328-1331, 1993.
31. Lee T, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C and Lee MT: Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 22: 1615-1627, 2002.
32. Einisto P, Watanabe M, Ishidate M and Nohmi T: Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreuctase or O-acetyltransferase activities. Mutation Res 259: 95-102, 1991.